To evaluate the efficacy and adverse effects of Azacitidine in combination with R-CHOP
(ARCHOP) for the treatment of TP53-mutated previously untreated Diffuse large B-cell lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Collaborators:
Chinese Academy of Medical Sciences Jiangsu Provincial People's Hospital Shanxi Province Cancer Hospital Sun Yat-sen University